ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma

ADAM metallopeptidase domain 12 (ADAM12) is a promising biomarker because of its low expression in normal tissues and high expression in a variety of human cancers. However, ADAM12 levels in ovarian cancer have not been well characterized. We previously identified ADAM12 as one of the signature gene...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Carcinogenesis
Main Authors: Cheon, Dong-Joo, Li, Andrew J., Beach, Jessica A., Walts, Ann E., Tran, Hang, Lester, Jenny, Karlan, Beth Y., Orsulic, Sandra
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Original Manuscript
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7500073/
https://ncbi.nlm.nih.gov/pubmed/25926422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgv059
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados